241 related articles for article (PubMed ID: 32920290)
1. Uncaria tomentosa reduces osteoclastic bone loss in vivo.
Lima V; Melo IM; Taira TM; Buitrago LYW; Fonteles CSR; Leal LKAM; Souza ASQ; Almeida TS; Costa Filho RND; Moraes MO; Cunha FQ; Fukada SY
Phytomedicine; 2020 Dec; 79():153327. PubMed ID: 32920290
[TBL] [Abstract][Full Text] [Related]
2. Genotoxicity and cytotoxicity of oxindole alkaloids from Uncaria tomentosa (cat's claw): Chemotype relevance.
Kaiser S; Carvalho ÂR; Pittol V; Dietrich F; Manica F; Machado MM; de Oliveira LF; Oliveira Battastini AM; Ortega GG
J Ethnopharmacol; 2016 Aug; 189():90-8. PubMed ID: 27180878
[TBL] [Abstract][Full Text] [Related]
3. Systemic administration of cytotoxic T lymphocyte-associated antigen 4 (CTLA-4)-Ig abrogates alveolar bone resorption in induced periodontitis through inhibition of osteoclast differentiation and activation: An experimental investigation.
Nakane S; Imamura K; Hisanaga R; Ishihara K; Saito A
J Periodontal Res; 2021 Oct; 56(5):972-981. PubMed ID: 34129238
[TBL] [Abstract][Full Text] [Related]
4. Chlorogenic acid inhibits osteoclast differentiation and bone resorption by down-regulation of receptor activator of nuclear factor kappa-B ligand-induced nuclear factor of activated T cells c1 expression.
Kwak SC; Lee C; Kim JY; Oh HM; So HS; Lee MS; Rho MC; Oh J
Biol Pharm Bull; 2013; 36(11):1779-86. PubMed ID: 23985829
[TBL] [Abstract][Full Text] [Related]
5. PF-3845, a Fatty Acid Amide Hydrolase Inhibitor, Directly Suppresses Osteoclastogenesis through ERK and NF-κB Pathways In Vitro and Alveolar Bone Loss In Vivo.
Ihn HJ; Kim YS; Lim S; Bae JS; Jung JC; Kim YH; Park JW; Wang Z; Koh JT; Bae YC; Baek MC; Park EK
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33671948
[TBL] [Abstract][Full Text] [Related]
6. Cyperus Rotundus L. extract suppresses RANKL-induced osteoclastogenesis through NFATc1/c-fos downregulation and prevent bone loss in OVX-induced osteoporosis rat.
Kum CJ; Kim EY; Kim JH; Lee B; Min JH; Heo J; Kim JH; Yeom M; Sohn Y; Jung HS
J Ethnopharmacol; 2017 Jun; 205():186-194. PubMed ID: 28315458
[TBL] [Abstract][Full Text] [Related]
7. Pueraria lobate Inhibits RANKL-Mediated Osteoclastogenesis Via Downregulation of CREB/PGC1β/c-Fos/NFATc1 Signaling.
Park KH; Gu DR; Jin SH; Yoon CS; Ko W; Kim YC; Lee SH
Am J Chin Med; 2017; 45(8):1725-1744. PubMed ID: 29121799
[TBL] [Abstract][Full Text] [Related]
8. OCLI-023, a Novel Pyrimidine Compound, Suppresses Osteoclastogenesis In Vitro and Alveolar Bone Resorption In Vivo.
Ihn HJ; Lee T; Kim JA; Lee D; Kim ND; Shin HI; Bae YC; Park EK
PLoS One; 2017; 12(1):e0170159. PubMed ID: 28085946
[TBL] [Abstract][Full Text] [Related]
9. Interleukin‑17A facilitates osteoclast differentiation and bone resorption via activation of autophagy in mouse bone marrow macrophages.
Song L; Tan J; Wang Z; Ding P; Tang Q; Xia M; Wei Y; Chen L
Mol Med Rep; 2019 Jun; 19(6):4743-4752. PubMed ID: 31059030
[TBL] [Abstract][Full Text] [Related]
10. Trapidil, a platelet-derived growth factor antagonist, inhibits osteoclastogenesis by down-regulating NFATc1 and suppresses bone loss in mice.
Kim SD; Kim HN; Lee JH; Jin WJ; Hwang SJ; Kim HH; Ha H; Lee ZH
Biochem Pharmacol; 2013 Sep; 86(6):782-90. PubMed ID: 23928189
[TBL] [Abstract][Full Text] [Related]
11. Sophorae Flos extract inhibits RANKL-induced osteoclast differentiation by suppressing the NF-κB/NFATc1 pathway in mouse bone marrow cells.
Kim JM; Lee JH; Lee GS; Noh EM; Song HK; Gu DR; Kim SC; Lee SH; Kwon KB; Lee YR
BMC Complement Altern Med; 2017 Mar; 17(1):164. PubMed ID: 28335757
[TBL] [Abstract][Full Text] [Related]
12. AZD8835 inhibits osteoclastogenesis and periodontitis-induced alveolar bone loss in rats.
Wang Y; Chen X; Chen X; Zhou Z; Xu W; Xu F; Zhang S
J Cell Physiol; 2019 Jul; 234(7):10432-10444. PubMed ID: 30652303
[TBL] [Abstract][Full Text] [Related]
13.
Kim JH; Shin H; Kim M; Kim S; Song K; Jung HS; Sohn Y
Mol Med Rep; 2021 Aug; 24(2):. PubMed ID: 34184079
[TBL] [Abstract][Full Text] [Related]
14. Ostericum koreanum Reduces LPS-Induced Bone Loss Through Inhibition of Osteoclastogenesis.
Kim JY; Ahn SJ; Baek JM; Yoon KH; Lee MS; Oh J
Am J Chin Med; 2015; 43(3):495-512. PubMed ID: 25967665
[TBL] [Abstract][Full Text] [Related]
15. Low dose of propranolol down-modulates bone resorption by inhibiting inflammation and osteoclast differentiation.
Rodrigues WF; Madeira MF; da Silva TA; Clemente-Napimoga JT; Miguel CB; Dias-da-Silva VJ; Barbosa-Neto O; Lopes AH; Napimoga MH
Br J Pharmacol; 2012 Apr; 165(7):2140-51. PubMed ID: 21950592
[TBL] [Abstract][Full Text] [Related]
16. Treatment of OPG-deficient mice with WP9QY, a RANKL-binding peptide, recovers alveolar bone loss by suppressing osteoclastogenesis and enhancing osteoblastogenesis.
Ozaki Y; Koide M; Furuya Y; Ninomiya T; Yasuda H; Nakamura M; Kobayashi Y; Takahashi N; Yoshinari N; Udagawa N
PLoS One; 2017; 12(9):e0184904. PubMed ID: 28937990
[TBL] [Abstract][Full Text] [Related]
17. The cross-talk between osteoclasts and osteoblasts in response to strontium treatment: involvement of osteoprotegerin.
Peng S; Liu XS; Huang S; Li Z; Pan H; Zhen W; Luk KD; Guo XE; Lu WW
Bone; 2011 Dec; 49(6):1290-8. PubMed ID: 21925296
[TBL] [Abstract][Full Text] [Related]
18. Selective blockade of voltage-gated potassium channels reduces inflammatory bone resorption in experimental periodontal disease.
Valverde P; Kawai T; Taubman MA
J Bone Miner Res; 2004 Jan; 19(1):155-64. PubMed ID: 14753747
[TBL] [Abstract][Full Text] [Related]
19. Honokiol inhibits osteoclast differentiation and function in vitro.
Hasegawa S; Yonezawa T; Ahn JY; Cha BY; Teruya T; Takami M; Yagasaki K; Nagai K; Woo JT
Biol Pharm Bull; 2010; 33(3):487-92. PubMed ID: 20190414
[TBL] [Abstract][Full Text] [Related]
20. Uncaria tomentosa Leaves Decoction Modulates Differently ROS Production in Cancer and Normal Cells, and Effects Cisplatin Cytotoxicity.
Kośmider A; Czepielewska E; Kuraś M; Gulewicz K; Pietrzak W; Nowak R; Nowicka G
Molecules; 2017 Apr; 22(4):. PubMed ID: 28417940
[No Abstract] [Full Text] [Related]
[Next] [New Search]
